[1]
M. Lima, S. Dutra, F. V. Gomes, T. Bilhim, and Élia Coimbra, “Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment”, Acta Med Port, vol. 31, no. 1, pp. 22–29, Jan. 2018.